₹992.20
-3.15 (-0.32%)
As of 18 Sept 2026, Jenburkt Pharmaceuticals Ltd share price is ₹992.20. The stock opened at ₹992.20 and had closed at ₹995.35 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹944.00 and a high of ₹1,321.00. In terms of performance, Jenburkt Pharmaceuticals Ltd share price has decreased by 1.88% over the past six months and has decreased by 10.07% over the last year.
JENBURPH Stock Price Chart
Jenburkt Pharmaceuticals Ltd Overview
Market cap₹439 Crs
Volume266
Prev. Close₹995.35
Year range₹944.00 - ₹1,321.00
ISININE354A01013
About JENBURPH
Jenburkt Pharmaceuticals is in the business of manufacturing, producing, developing and marketing a wide range of branded Pharmaceuticals and health care products.
Jenburkt Pharmaceuticals Ltd Historical Performance
1 Month Return-5.21%
6 Month Return-2.07%
3 Year Return42.19%
3 Month Return-13.96%
1 Year Return-10.46%
5 Year Return104.15%
Jenburkt Pharmaceuticals Ltd Fundamentals
ROCE(TTM)23.20%
P/E Ratio (TTM)13.38
P/B Ratio2.23
Debt to Equity0.01
ROE17.63%
EPS (TTM)80.96
Dividend Yield2.08%
Book Value446.47
Profit Margin21.18%
Operating Margin22.40%
Jenburkt Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 179.04 | 158.41 | 146.64 | 141.87 | 128.93 |
| EBITDA | 50.09 | 47.11 | 37.79 | 35.49 | 32.20 |
| Net Profit | 34.74 | 32.06 | 25.98 | 24.61 | 22.30 |
| EPS | 78.71 | 72.65 | 58.86 | 53.90 | 48.58 |
Jenburkt Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 978.85 |
| Resistance 1 (R1) | 1,008.05 |
| Pivot Point | 991.55 |
Jenburkt Pharmaceuticals Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 28-Aug-2026 | 05-May-2026 | 28-Aug-2026 | Final | ₹20.70 |
| 11-Jul-2025 | 20-May-2025 | 11-Jul-2025 | Final | ₹18.00 |
| 23-Jul-2024 | 28-May-2024 | 24-Jul-2024 | Final | ₹15.30 |
| 19-Jul-2023 | 23-May-2023 | 20-Jul-2023 | Final | ₹14.40 |
| 21-Jul-2022 | 27-May-2022 | 23-Jul-2022 | Final | ₹12.00 |
JENBURPH Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Ashish U Bhuta | Chairman |
| Dilip H Bhuta | Whole Time Director |
| Hina Ravindra Mehta | Non Executive Independent Director |
Jenburkt Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,863.60+0.54% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,290.00+1.44% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,829.50+0.35% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Jenburkt Pharmaceuticals Ltd today is ₹992.20 on NSE and ₹992.20 on BSE.
- The 52-week high of Jenburkt Pharmaceuticals Ltd is ₹1,321.00, while the 52-week low is ₹944.00.
- The current market capitalisation of Jenburkt Pharmaceuticals Ltd is approximately ₹439 crore.
- The P/E (Price-to-Earnings) ratio of Jenburkt Pharmaceuticals Ltd is 13.38. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Jenburkt Pharmaceuticals Ltd is 2.23. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Jenburkt Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for JENBURPH on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Jenburkt Pharmaceuticals Ltd has delivered a return of approximately 42.19%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Jenburkt Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 46.62% promoters, 0.00% FIIs, 0.12% DIIs, and 41.05% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
